Immunophage is a clinical-stage biotechnology company dedicated to discovering, developing and commercializing innovative medicines for patients worldwide. We strengthen our R&D pipeline by exploring novel disease pathogenesis, identifying and validating cutting-edge targets, and developing both small-molecule and large-molecule therapeutics.
By integrating in-house R&D strengths and strategic cooperation with global biopharmaceutical partners, we strive to advance two innovative drug candidates into clinical trials each year.
View More
As a fast-growing clinical-stage biotech company,
we are committed to developing transformative innovative medicines
to benefit patients globally. We foster an open, inclusive, and innovative work atmosphere,
offering outstanding talents broad career development platforms and growth opportunities.
View More
Cpyright © 2025 Nanjing Immunophage Biomedical Co.,Ltd
All Rights Reserved. 苏ICP备2022026466号-1 
苏公网安备 32011202000830号
